SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/05E74789387E5D4AE38C59CD3D9E1A089EFD9622F07E476D3058DA02A86F3ED2D82AF0ECB59967DBFB170C742E1C9D14>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/05E74789387E5D4AE38C59CD3D9E1A089EFD9622F07E476D3058DA02A86F3ED2D82AF0ECB59967DBFB170C742E1C9D14
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/05E74789387E5D4AE38C59CD3D9E1A089EFD9622F07E476D3058DA02A86F3ED2D82AF0ECB59967DBFB170C742E1C9D14
http://www.w3.org/2000/01/rdf-schema#comment
"Collectively these data indicated that ATR or ATM inhibition represent potential therapeutic strategies for the treatment of AML especially MLL-driven leukemias."
xsd:string
http://purl.uniprot.org/uniprot/#_4C64567B4E71F95E626FF612C7DE79E90900288959DAF5512CF9FE305D2E09DC01B8C0483D41154591844E8046E3BB7B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/05E74789387E5D4AE38C59CD3D9E1A089EFD9622F07E476D3058DA02A86F3ED2D82AF0ECB59967DBFB170C742E1C9D14
http://purl.uniprot.org/uniprot/Q13535
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/05E74789387E5D4AE38C59CD3D9E1A089EFD9622F07E476D3058DA02A86F3ED2D82AF0ECB59967DBFB170C742E1C9D14
http://purl.uniprot.org/uniprot/#_Q13535-mappedCitation-27625305
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/05E74789387E5D4AE38C59CD3D9E1A089EFD9622F07E476D3058DA02A86F3ED2D82AF0ECB59967DBFB170C742E1C9D14